The Eugene and Marilyn Glick Eye Institute has become a leader among public universities in the NIH rankings due to recent faculty appointments, new avenues of research and the expansion of our existing programs in basic, translational and clinical research.
The research portfolio of the department is broad but with emphasis on understanding and treating age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, ocular tumors and pediatric eye diseases. To achieve this the faculty have evolved expertize in a range of areas including: vascular biology, stem cell biology, cancer biology, blood flow, cilia, retinal regeneration, innervation, animal models, circadian rhythm, aging, oxidative stress, cell signaling, genetic profiling, glaucoma medical therapy, glaucoma surgical devices and new therapeutic approaches to dry eye and ocular surface disease.
Basic and Translational Research, under the direction of Michael Boulton, Ph.D., has almost 40 scientists, both professional and student, working on novel and innovative discoveries in vision research.
The department also has a history of specialized Clinical Research, led by Alon Harris, M.S., Ph.D., FARVO, and brings together a collaborative international team of world-class vision researchers. Operating within Clinical Research is the Glaucoma Research and Diagnostic Center. The GRDC is a reading site for multiple international ocular blood flow studies being conducted in dozens of countries and has an international presence through international collaboration and mentorships.
The research focus of the department continues to grow with new and exciting discoveries being investigated. Visit the individual faculty pages to find out more about their current research projects. The Department of Ophthalmology recognizes that this important work would not be possible without the support of partner organizations who share in our commitment to vision research. As such, we would like to recognize the ongoing contributions provided by the Glick Family Foundation, the Central Indiana Community Foundation, and Research to Prevent Blindness.